You searched for liver disease | Page 39 of 398

HER2-ultralow Metastatic Breast Cancer Companion Diagnostic Approved by FDA

Posted by Chris Wolski | Feb 4, 2025 | Breast |

Roche’s PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.

Carna Health is revolutionizing CKD detection by integrating AI-driven analytics with real-time, point-of-care (POC) testing.

Posted by Andy Lundin | Feb 3, 2025 | Prostate |

Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.

Posted by Andy Lundin | Jan 30, 2025 | Sequencing Systems |

Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.

Posted by Andy Lundin | Jan 30, 2025 | Womens Health |

The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.